BackgroundCheck.run
Search For

Thomas S Felker, 78PO Box 761, Manson, WA 98831

Known as:
Thomas Stratton Felker Marian L Felker Marian Lyle Felker Marian T Felker Tom S Felker Tom Selker L R
Related to:
Mary E Felker 68

Thomas Felker Phones & Addresses

Manson, WA   

Phoenix, AZ   

Scottsdale, AZ   

Seattle, WA   

11344 Mccormick Pl, Vashon, WA 98070    206-5674282   

Paia, HI   

Kiona, WA   

Maricopa, AZ   

Work

Address: Po Box 3613, Seattle, WA 98124

Ranks

Licence: Washington - Active Date: 1971
Get Report
Control this profile

Mentions for Thomas S Felker

Career records & work history

Lawyers & Attorneys

Thomas Felker Photo 1

Thomas Stratton Felker, Seattle WA - Lawyer

Address:
Po Box 3613, Seattle, WA 98124
206-4124329 (Office)
Licenses:
Washington - Active 1971

License Records

Thomas Lee Felker

Licenses:
License #: 6763 - Active
Issued Date: Jan 26, 1982
Renew Date: Dec 1, 2015
Expiration Date: Nov 30, 2017
Type: Certified Public Accountant

Thomas Felker resumes & CV records

Resumes

Thomas Felker Photo 16

Thomas Felker

Thomas Felker Photo 17

Gameplay Engineer At Sledgehammer Games

Location:
San Francisco Bay und Umgebung
Industry:
Computer-Software
Thomas Felker Photo 18

Independent Medical Marketing And Advertising Professional

Location:
Groraum Milwaukee und Umgebung
Industry:
Marketing und Werbung
Thomas Felker Photo 19

Cpa At Thomas Lee Felker, Cpa

Location:
Groraum Denver und Umgebung
Industry:
Buchhaltung

Publications & IP owners

Us Patents

Tgf- Polypeptides, Functional Fragments And Methods Of Use Therefor

US Patent:
6677307, Jan 13, 2004
Filed:
May 1, 2002
Appl. No.:
10/138158
Inventors:
Daniel R. Twardzik - Bainbridge Island WA
Andre Pernet - Lake Forest IL
Thomas S. Felker - Vashon WA
Stefan Paskell - Bainbridge Island WA
John M. Reno - Brier WA
Assignee:
Kaleidos Pharma, Inc. - Seattle WA
International Classification:
A61K 3818
US Classification:
514 12, 530300, 530402
Abstract:
Disclosed are TGF-60 mimetics that PEGylated TGF- polypeptides and PEGylated TGF-60 related polypetides or fragments thereof.

Loop Peptide And Tgf For Stimulating Stem Cell Proliferation And Migration

US Patent:
6764683, Jul 20, 2004
Filed:
Dec 13, 1999
Appl. No.:
09/459813
Inventors:
Daniel R. Twardzik - Bainbridge Island WA
Stefan Paskell - Bainbridge Island WA
Thomas S. Felker - Vashon WA
Assignee:
Kaleidos Pharma, Inc. - Seattle WA
International Classification:
A61K 3819
US Classification:
4241981, 514 15, 514 2, 530324, 530327, 530300, 530317, 530402, 424 85, 930120
Abstract:
There is disclosed a novel genus of small peptides, much smaller than human TGF, was discovered as having TGF biological activity and therefore are useful as pharmacologic agents for the same indications as full length TGF polypeptide. There is further disclosed that TGF and consequently the genus of small peptides disclosed herein, was found to have therapeutic activity to stimulate hematopoiesis in patients undergoing cytotoxic cancer chemotherapy and to act as a cytoprotective agent to protect a patient undergoing cancer cytotoxic therapy from gastrointestinal (GI) side effects, such as mucositis and otherwise support the barrier function of the GI tract when it is harmed by cytotoxic therapy.

Tgf- Polypeptides, Functional Fragments And Methods Of Use Therefor

US Patent:
6815418, Nov 9, 2004
Filed:
Aug 17, 2001
Appl. No.:
09/932172
Inventors:
Daniel R. Twardzik - Bainbridge Island WA
Andre Pernet - Lake Forest IL
Thomas S. Felker - Vashon WA
Stefan Paskell - Bainbridge Island WA
Assignee:
Kaleidos Pharma, Inc. - Seattle WA
International Classification:
A61K 3818
US Classification:
514 12, 514866, 530300, 530324
Abstract:
Disclosed are TGF- polypeptides, related polypeptides, fragments and mimetics thereof useful in stimulating stem cell or precursor cell proliferation, migration and differentiation. The methods of the invention are useful to treat tissue injury as well as expand stem cell populations in, or obtained from, gastrointestinal, musculoskeletal, urogenital, neurological and cardiovascular tissues. The methods include ex vivo and in vivo applications.

Tgf-Α Polypeptides, Functional Fragments And Methods Of Use Therefor

US Patent:
7329645, Feb 12, 2008
Filed:
Jan 15, 2002
Appl. No.:
10/050190
Inventors:
Daniel R. Twardzik - Bainbridge Island WA, US
Andre Pernet - Lake Forest IL, US
Thomas S. Felker - Vashon WA, US
Stefan Paskell - Bainbridge Island WA, US
Assignee:
Applied Protein Sciences, LLC - Mountain View CA
International Classification:
A61K 38/16
A61K 38/19
US Classification:
514 12, 514 2, 530300
Abstract:
Disclosed are TGF-α polypeptides, related polypeptides, fragments and mimetics thereof useful in stimulating stem cell or precursor cell proliferation, migration and differentiation. The methods of the invention are useful to treat tissue injury as well as expand stem cell populations in, or obtained from, gastrointestinal, musculoskeletal, urogenital, neurological and cardiovascular tissues. The methods include ex vivo and in vivo applications.

Loop Peptide And Tgfα For Stimulating Stem Cell Proliferation And Migration

US Patent:
7365172, Apr 29, 2008
Filed:
Jul 16, 2004
Appl. No.:
10/893172
Inventors:
Daniel R Twardzik - Bainbridge Island WA, US
Stefan Paskell - Bainbridge Island WA, US
Thomas S Felker - Vashon WA, US
Assignee:
Applied Protein Sciences LLC - Mountain View CA
International Classification:
A61K 38/22
C07K 1/00
US Classification:
530399, 530324, 530402, 4241981, 4242781, 514 2
Abstract:
There is disclosed a novel genus of small peptides, much smaller than human TGFα, was discovered as having TGFα biological activity and therefore are useful as pharmacologic agents for the same indications as full length TGFα polypeptide. There is further disclosed that TGFα and consequently the genus of small peptides disclosed herein, was found to have therapeutic activity to stimulate hematopoiesis in patients undergoing cytotoxic cancer chemotherapy and to act as a cytoprotective agent to protect a patient undergoing cancer cytotoxic therapy from gastrointestinal (GI) side effects, such as mucositis and otherwise support the barrier function of the GI tract when it is harmed by cytotoxic therapy.

Method For Stimulating Hematopoiesis Using Tgf-Alpha

US Patent:
2002009, Jul 25, 2002
Filed:
Apr 26, 1999
Appl. No.:
09/299473
Inventors:
DANIEL R. TWARDZIK - BAINBRIDGE ISLAND WA, US
THOMAS S. FELKER - VASHON WA, US
STEFAN L. PASKELL - BAINBRIDGE ISLAND WA, US
International Classification:
A61K038/00
A01N037/18
C07K001/00
C07K014/00
C07K017/00
US Classification:
514/012000, 514/002000, 530/351000
Abstract:
There is disclosed a novel genus of small peptides, much smaller than TGF, was discovered as having TGF biological activity and therefore are useful as pharmacologic agents for the same indications as full length TGF polypeptide. There is further disclosed that TGF and consequently the genus of small peptides disclosed herein, was found to have therapeutic activity to stimulate hematopoiesis in patients undergoing cytotoxic cancer chemotherapy and to act as a cytoprotective agent to protect a patient undergoing cancer cytotoxic therapy from gastrointestinal (GI) side effects, such as mucositis and otherwise support the barrier function of the GI tract when it is harmed by cytotoxic therapy.

Tgf-Alpha Polypeptides, Functional Fragments And Methods Of Use Therefor

US Patent:
2002016, Nov 14, 2002
Filed:
Sep 12, 2001
Appl. No.:
09/955581
Inventors:
Daniel Twardzik - Bainbridge Island WA, US
Stefan Paskell - Bainbridge Island WA, US
Thomas Felker - Vashon WA, US
International Classification:
A61K038/08
C07K007/06
US Classification:
514/015000, 530/328000
Abstract:
Disclosed are peptides related to human TGF-, having TGF- biological activity, which are useful for many of the indications that full-length TGF- polypeptide is useful. Also provided are methods of use of such peptides, as well as human TGF- and biologically related polypeptides. For example, methods for treating or preventing cachexia in subjects are provided as well as methods for stimulating hematopoiesis in patients undergoing cytotoxic chemotherapy. In addition, the use of TGF- related peptides to related neurodengenerative diseases is also provided. Methods of the invention also provide protection for patients undergoing cytotoxic therapy from side effects such as gastrointestinal (GI) mucositis.

Tgf-Alpha Polypeptides, Functional Fragments And Methods Of Use Therefor

US Patent:
2002019, Dec 19, 2002
Filed:
Jan 4, 2002
Appl. No.:
10/039119
Inventors:
Daniel Twardzik - Bainbridge Island WA, US
Andre Pernet - Lake Forest IL, US
Thomas Felker - Vashon WA, US
Stefan Paskell - Bainbridge Island WA, US
Assignee:
Stem Cell Pharmaceuticals, Inc.
International Classification:
A61K038/18
US Classification:
514/012000
Abstract:
Disclosed are TGF- polypeptides, related polypeptides, fragments and mimetics thereof useful in stimulating cell or precursor cell proliferation, migration and differentiation. The methods of the invention are useful to treat tissue injury as well as expand stem cell populations in, or obtained from, gastrointestinal, musculoskeletal, urogenital, neurological and cardiovascular tissues. The methods include ex vivo and in vivo applications.

Possible Relatives

David M Felker  Darold H Felker  Donna B Felker  Dustin L Felker  Elizabeth A Felker  Eugene P Felker  Frank N Felker  Thomas D Johnson  Thomas Stamps  Thomas W Stancil 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.